Autologous culture method improves retention of tumors' native properties.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 11 2020
Historique:
received: 15 02 2020
accepted: 02 11 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 23 3 2021
Statut: epublish

Résumé

No current in vitro tumor model replicates a tumor's in vivo microenvironment. A culturing technique that better preserves a tumor's pathophysiological conditions is needed for some important clinical applications, including personalized drug-sensitivity/resistance assays. In this study, we utilized autologous serum or body fluid to build a 3D scaffold and grow a patient's tumor. We named this technique "3D-ACM" (autologous culture method). Forty-five clinical samples from biopsies, surgically removed tumor tissues and malignant body fluids were cultured with 3D-ACM. Traditional 3D-FBS (fetal bovine serum) cultures were performed side-by-side for comparison. The results were that cells cultured in 3D-ACM rebuilt tissue-like structures, and retained their immuno-phenotypes and cytokine productions. In contrast, the 3D-FBS method promoted mesenchymal cell proliferation. In preliminary chemo drug-sensitivity assays, significantly higher mortality was always associated with FBS-cultured cells. Accordingly, 3D-ACM appears to more reliably preserve a tumor's biological characteristics, which might improve the accuracy of drug-testing for personalized cancer treatment.

Identifiants

pubmed: 33235257
doi: 10.1038/s41598-020-77238-0
pii: 10.1038/s41598-020-77238-0
pmc: PMC7686378
doi:

Substances chimiques

Antineoplastic Agents 0
Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20455

Références

Cell. 2016 Jun 16;165(7):1586-1597
pubmed: 27315476
Elife. 2016 Nov 15;5:
pubmed: 27845624
Anticancer Res. 2015 May;35(5):2709-13
pubmed: 25964549
Cell. 2015 Jan 15;160(1-2):324-38
pubmed: 25557080
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Nature. 2014 Dec 18;516(7531):400-4
pubmed: 25363776
J Cell Biochem. 2001 Jun 26-Jul 25;83(1):121-8
pubmed: 11500960
Tissue Eng. 2005 Jan-Feb;11(1-2):41-9
pubmed: 15738660
Cold Spring Harb Perspect Biol. 2016 May 02;8(5):
pubmed: 27141051
J Tissue Eng Regen Med. 2015 Mar;9(3):310-4
pubmed: 23307775
Nat Med. 2017 Jul 11;23(7):796-799
pubmed: 28697178
Curr Opin Biotechnol. 2017 Oct;47:23-29
pubmed: 28578251
Cell. 2014 Sep 25;159(1):176-187
pubmed: 25201530
Am J Pathol. 2007 Dec;171(6):2048-57
pubmed: 18055559
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195692
Front Pharmacol. 2018 Jan 23;9:6
pubmed: 29410625
Proc Natl Acad Sci U S A. 1985 Jan;82(1):119-23
pubmed: 3871521
Nat Commun. 2015 Feb 27;6:6169
pubmed: 25721094
Comb Chem High Throughput Screen. 2017;20(5):451-457
pubmed: 28155598
Front Oncol. 2015 Dec 17;5:282
pubmed: 26734568
Nature. 2015 May 7;521(7550):43-7
pubmed: 25924068
Nat Rev Cancer. 2018 Jul;18(7):407-418
pubmed: 29692415
Tissue Eng Part C Methods. 2008 Sep;14(3):261-71
pubmed: 18694322
Matrix Biol. 2009 Apr;28(3):137-47
pubmed: 19243701
J Tissue Eng. 2010 Nov 07;2010:218142
pubmed: 21350642
Cancer Res Treat. 2018 Jan;50(1):1-10
pubmed: 28903551
Physiol Rev. 2016 Jul;96(3):1025-1069
pubmed: 33003261
Curr Opin Immunol. 2017 Oct;48:15-22
pubmed: 28756233
Trends Mol Med. 2017 May;23(5):393-410
pubmed: 28341301
Science. 2018 Feb 23;359(6378):920-926
pubmed: 29472484
J Natl Cancer Inst. 1961 Jul;27:1-15
pubmed: 13694182

Auteurs

Yao Tang (Y)

Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou, 515041, Guangdong, China. ytang092651@gmail.com.
Dalian Municipal Central Hospital, Dalian, 116033, Liaoning, China. ytang092651@gmail.com.

Qian Xu (Q)

Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou, 515041, Guangdong, China.

Meiling Yan (M)

Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou, 515041, Guangdong, China.

Yimin Zhang (Y)

Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou, 515041, Guangdong, China.

Ping Zhu (P)

Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou, 515041, Guangdong, China.

Xianghong Li (X)

Department of Pathology, Beijing University Cancer Hospital, Beijing, 100142, China.

Limin Sang (L)

Dalian Municipal Central Hospital, Dalian, 116033, Liaoning, China.

Ming Zhang (M)

Dalian Municipal Central Hospital, Dalian, 116033, Liaoning, China.

Wenhe Huang (W)

Cancer Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, China.

Lianxing Lin (L)

Shantou Central Hospital, Shantou, 515041, Guangdong, China.

Jundong Wu (J)

Cancer Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, China.

Yue Xin (Y)

Dalian Municipal Central Hospital, Dalian, 116033, Liaoning, China.

Junhui Fu (J)

Shantou Central Hospital, Shantou, 515041, Guangdong, China.

Li Zhang (L)

Dalian Municipal Central Hospital, Dalian, 116033, Liaoning, China.

Shuming Zhang (S)

Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou, 515041, Guangdong, China.

Jiang Gu (J)

Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou, 515041, Guangdong, China. 2523381625@qq.com.
Jinxin Research Institute for Reproductive Medicine and Genetics, Chengdu Jinjiang Hospital for Maternal and Child Health Care, Chengdu, 610066, Sichuan, China. 2523381625@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH